Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Other financing activities (2020 - 2025)

Historic Other financing activities for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to -$539000.0.

  • Sotera Health's Other financing activities rose 1551.72% to -$539000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 297272.73%. This contributed to the annual value of -$2.3 million for FY2024, which is 2761.48% down from last year.
  • As of Q3 2025, Sotera Health's Other financing activities stood at -$539000.0, which was up 1551.72% from -$789000.0 recorded in Q2 2025.
  • Sotera Health's 5-year Other financing activities high stood at $24.5 million for Q1 2023, and its period low was -$26.6 million during Q2 2023.
  • Its 5-year average for Other financing activities is -$61473.7, with a median of -$418000.0 in 2022.
  • Data for Sotera Health's Other financing activities shows a peak YoY increase of 595095.69% (in 2023) and a maximum YoY decrease of 406598.75% (in 2023) over the last 5 years.
  • Sotera Health's Other financing activities (Quarter) stood at $74000.0 in 2021, then tumbled by 590.54% to -$363000.0 in 2022, then surged by 525.9% to $1.5 million in 2023, then plummeted by 143.47% to -$672000.0 in 2024, then increased by 19.79% to -$539000.0 in 2025.
  • Its Other financing activities stands at -$539000.0 for Q3 2025, versus -$789000.0 for Q2 2025 and -$704000.0 for Q1 2025.